Cargando…

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer

In the past few decades, tumor diagnosis and treatment theory have developed in a variety of directions. The number of people dying from pancreatic cancer increases while the mortality rate of other common tumors decreases. Traditional imaging methods show the boundaries of pancreatic tumor, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Kai, Wang, Xiangkun, Zhang, Xudong, Liu, Zhongyuan, Huang, Shuai, Li, Renfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293050/ https://www.ncbi.nlm.nih.gov/pubmed/35860591 http://dx.doi.org/10.3389/fonc.2022.933645

Ejemplares similares

Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors
por: Huang, Shuai, et al.
Publicado: (2022)

Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition
por: Huang, Shuai, et al.
Publicado: (2022)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022)

The Value of Circulating Circular RNA in Cancer Diagnosis, Monitoring, Prognosis, and Guiding Treatment
por: Zhang, Yunjing, et al.
Publicado: (2021)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity
por: Yang, Xiao, et al.
Publicado: (2022)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients
por: Qian, Chengcheng, et al.
Publicado: (2021)

The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis
por: Shi, Bian, et al.
Publicado: (2021)

Prognostic value of epithelial–mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis
por: Zhao, Qiang, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer
por: Li, Lincheng, et al.
Publicado: (2022)

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
por: Jiang, Jiahong, et al.
Publicado: (2020)

Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma
por: Guan, Tao, et al.
Publicado: (2022)

Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors
por: Zhang, Yajing, et al.
Publicado: (2022)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
por: Lee, Hee Seung, et al.
Publicado: (2023)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis
por: Yin, Hua, et al.
Publicado: (2022)

The value of metabolic LncRNAs in predicting prognosis and immunotherapy efficacy of gastric cancer
por: Du, Peizhun, et al.
Publicado: (2023)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
por: Luo, Yiqiao, et al.
Publicado: (2022)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
por: Li, Ying, et al.
Publicado: (2023)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
por: Amantini, Consuelo, et al.
Publicado: (2019)

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
por: Botrus, Gehan, et al.
Publicado: (2022)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer
por: Chen, Hui, et al.
Publicado: (2022)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms
por: Wang, Huan, et al.
Publicado: (2022)

Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy
por: Wang, Xiaoguang, et al.
Publicado: (2021)

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
por: Liu, Ruoyan, et al.
Publicado: (2019)

Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes
por: Wang, Xiaoqin, et al.
Publicado: (2022)

The Prognostic Value of a Tumor Microenvironment-Based Immune Cell Infiltration Score Model in Colon Cancer
por: Tang, Xingkui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_km7qrvbaps1dmavnn6tr20rkpj